SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 71 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $255,000 | +23.2% | 17,025 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $207,000 | -20.1% | 17,025 | +4.7% | 0.00% | 0.0% |
| Q4 2015 | $259,000 | +4.0% | 16,255 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $249,000 | -39.1% | 16,255 | -3.4% | 0.00% | -33.3% |
| Q2 2015 | $409,000 | +1.7% | 16,835 | -2.6% | 0.00% | 0.0% |
| Q1 2015 | $402,000 | -7.4% | 17,285 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $434,000 | -19.3% | 17,285 | 0.0% | 0.00% | -25.0% |
| Q3 2014 | $538,000 | +20.4% | 17,285 | 0.0% | 0.00% | +33.3% |
| Q2 2014 | $447,000 | +36.3% | 17,285 | +23.1% | 0.00% | +50.0% |
| Q1 2014 | $328,000 | -28.2% | 14,042 | -21.9% | 0.00% | -33.3% |
| Q4 2013 | $457,000 | +60.4% | 17,990 | +28.8% | 0.00% | +50.0% |
| Q3 2013 | $285,000 | -2.7% | 13,970 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $293,000 | – | 13,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
| GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
| Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
| Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
| HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
| Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
| JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
| Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |